Skip to main content

Table 2 Clinical characteristics of patients, underlying diseases and abscess’ characteristics

From: The role of Enterococcus spp. and multidrug-resistant bacteria causing pyogenic liver abscesses

Variable

No. of patients (%)

Comorbiditiesa

 Malignancy

32 (34.9)

 Diabetes mellitus

21 (24.4)

 Liver cirrhosis

14 (16,3)

 Liver transplantation

10 (11.6)

Direct cause of abscess

 Bile duct stenosis/obstruction

27 (31.4)

 Anastomosis leakage

13 (15.1)

 Biliary infection

13 (15.1)

 Superinfected liver metastasis

8 (9.3)

 Ischemic

5 (5.8)

 Intra-abdominal infection

2 (2.3)

 Non-intestinal sepsis

4 (4.7)

 Cryptogenic

14 (16.3)

History of prior abdominal surgery

40 (57.0)

History of prior ERCP/PTCD

56 (53.5)

PLA under laid-in biliary stent

33 (38.4)

Initial symptomsa

 Fever

51 (59.3)

 Right upper quadrant pain

41 (47.7)

 Chills

14 (16.3)

 Jaundice

10 (11.6)

 Unspecific abdominal pain

6 (7.0)

 Other

30 (34.9)

 None

3 (3.5)

Number of abscess

One

57 (66.3)

Two

12 (14.0)

Multiple

17 (19.8)

Size of abscess (diameter)

  < 5 cm

25 (29.1)

 5–10 cm

33 (38.4)

  > 10 cm

11 (12.8)

 Not documented

17 (19.8)

  1. Abbreviations: ERCP endoscopic retrograde cholangiopancreatography, PTCD percutaneous transhepatic cholangiography and drainage
  2. aPatients fit to plural categories were counted in each category